Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Sun Pharmaceutical Industries Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524715
ISIN Demat	INE044A01036
Book Value	104.58

NSE Code	SUNPHARMA
Dividend Yield %	1.01
Market Cap	3796587.69

P/E	79.12
EPS	20.00
Face Value	1


	BSE		NSE

04-Sep-2025

Last Price	1582.35
Net Change	2.75
% Change	0.17%
Prev.Close	1579.60
Open	1591.30
High	1599.00
Low	1561.50
Volume	136829

Last Price	1582.30
Net Change	3.6
% Change	0.23%
Prev.Close	1578.70
Open	1597.00
High	1597.00
Low	1561.00
Volume	2298657

Value	214986213
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1599.00
52-Week High	1960.20
52-Week Low	1555.00

Value	3618588413.7
Best Buy	0.00
Best Sell	1582.30
Best Quantity	0
Sell Quantity	53
Today's Range	1597.00
52-Week High	1960.35
52-Week Low	1553.05

Open Price	1592.50
High Price	1593.70
Low Price	1568.90
Last Price	1585.40
Prev Close	1583.60
Change	1.80
% Change	0.11 %

Average Price	1580.38
Underlying Value	1582.30
Number of contracts traded	5267
Turnover in Rs. Lakhs	29134
Open Interest	14631750.00
Change in O I	-277200.00
% Change in O I	-1.86 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	53
Price	1582.30

Best Bid

Best Offer

Quantity	700
Price	1583.6

Quantity	350
Price	1584.1

Holding Details

Latest Corporate Events

Bonus

1 : 1

29-Jul-13

Book Closure

25-Aug-21

31-Aug-21

Dividend

550 %

07-Jul-25

Company News

04-08-2025

Sun Pharmaceutical Indust...

01-08-2025

Clarification sought fro...

31-07-2025

Sun Pharmaceutical Indust...

21-07-2025

Sun Pharmaceutical Indus...

18-07-2025

Sun Pharma incorporates s...

15-07-2025

Sun Pharmaceutical Indust...

15-07-2025

Sun Pharmaceutical Indust...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.